(PRESS RELEASE) MELBOURNE, Australia, 3-Feb-2022 — /EuropaWire/ — Australian technologist Dr Ian Dixon founded Exopharm in 2013 with the vision to harness the unique properties of exosomes as a new class of medicine. Dixon’s decisive early entry into exosome therapeutics … Read the full press release →
Posted in Healthcare, Pharma & Biotech, Science, Technology
Tagged AAVs, adeno-associated viral vectors, Arch Ventures, Australian technologist, Biotech, Codiak Biociences, Daisy Scarborough, DNA/RNA, Dr Ian Dixon, Evox Therapeutics, EVPS, Exopharm, Exoria, exosome therapeutics, exosomes, gene therapies, genetic disorders, LEAP™, lipid nanoparticles, LNPs, LOAD, Lonza, medicine, Pharmaceutical, vaccines